The Affirm prone biopsy system is the first dedicated prone biopsy system capable of both stereotactic and tomosynthesis-guided breast biopsies. The Affirm prone biopsy system is CE marked and pending 510k clearance in the U.S. The new system complements Hologic’s Selenia Dimensions mammography system and Affirm upright biopsy system to ensure that facilities have all the options necessary to provide minimally invasive breast biopsy to their patients. The Affirm prone system provides enhanced biopsy performance over existing prone systems with exceptional biopsy imaging capabilities using the same detector technology as the Hologic tomosynthesis mammography system; a streamlined workflow designed to make the system fast and easy to use; access to challenging lesion locations with a fully integrated C-arm. The C-arm allows a full 360° access to the breast with both standard and lateral needle approaches—without requiring additional accessory attachments.
Read more

E-CUBE 11, the newest addition to the E-CUBE product portfolio. Built around the latest imaging technologies, equipped with a rich set of high-end features, the mid-range system offers anewly designed interface combined with advanced imaging solutions for shared services including general imaging, obstetrics & gynecology and internal medicine. In order to effectively manage demanding caseloads, the E-CUBE 11 features a simplified way of scanning with more programmable keys and a new touch screen, leading to about 28% reduced exam time and faster workflow with 35% fewer keystrokes on average, compared with a conventional system. Powered by an intuitive interface of a capacitive touch screen (10.4") with instant response, the system promotes streamlined exam flows to improve exam quality with less effort. Its new usability concept for UI/UX design also helps reduce repetitive movements and even a learning curve, providing a new level of user performance. Additional advantage of the enhanced CPU (Intel Core i7) and integrated SSD (Solid-State Drive) increases process efficiency and patient throughput by the E-CUBE 11 system. Based on Alpinion’s Crystal Signature Technology, the newly adaptive imaging algorithm and enhanced digital signal processing enable the E-CUBE 11 system to process more information and faster for diagnosis with exceptional detail, clearer border definition and the ability to assess subtle changes in tissue. The E-CUBE 11 system delivers a high level of image performance across a wide range of clinical applications and patient body types. Without compromise between frame rate and image quality, it improves temporal resolution with up to 200% higher frame rate and 150% better colour PRF. A newly adaptive post processing by each application delivers clearer image detail and contrast resolution by increased signal-to-noise ratio and a wider range of gray scales. The introduction of the HD Digital Beamforming enables consistently excellent image quality from near to far field zone across all clinical capabilities. Suitable for a shared service environment, the E-CUBE 11 has the power and application diversity to support a spectrum of specialties from general imaging to OB/GYN, cardiology and more.
Read more

Carestream Health makes converting to DR easy and affordable with the launch of its CARESTREAM DRX-Transportable System/Lite. This system equips facilities to convert room-based or mobile imaging systems to DR through use of a wireless tablet PC that gives users complete control of the X-ray system and displays diagnostic images as they are acquired. Control from the wireless tablet eliminates the need to interface with a generator and use a cable connection, which delivers exceptional flexibility and saves both time and money. An access point in the detector communicates with the access point in the tablet to create a flexible solution that enhances workflow. The ability to quickly and easily convert CR systems to DR with the use of Carestream’s wireless tablet offers significant advantages for healthcare providers. The lightweight wireless tablet equips users to capture DR exams from any room-based or mobile imaging system while moving freely throughout the radiology department and the hospital. This system uses a virtual access point in the DRX detector to manage image capture and display images on the tablet. The tablet PC is self-powered and rechargeable. It has a 12-inch touch screen and weighs just 3.6 pounds (1.63 Kg). This new system is available in the United States, Canada, Europe and selected countries around the world.
Read more

Hitachi Aloka has developed two different styles of diagnostic ultrasound systems to meet these needs. ARIETTA Precision supports surgical treatment and acute healthcare, while ARIETTA Prologue has been designed especially for the POC (Point of Care) ultrasound market where often new users are looking for ultrasound to provide better chronic and community healthcare. ARIETTA Precision has a slim profile with a large 21.5
Read more

Abbott has received the CE Mark for TriClip™ Transcatheter Tricuspid Valve Repair System which is now approved for use in Europe and other countries that recognize CE Mark. The device is used as a non-surgical treatment for people with a leaky tricuspid valve, a condition known as tricuspid regurgitation (TR).
With the CE Mark designation, Abbott’s TriClip device is the first minimally invasive, clip-based tricuspid valve repair device to be commercially available in the world.
Abbott is a global leader in developing transcatheter treatments for heart valve disorders and has brought to market three first-in-class therapies for structural heart disease: MitraClip for mitral valve repair, Tendyne™ for mitral valve replacement, and now TriClip to treat the tricuspid valve.
The tricuspid valve, often referred to as the “forgotten heart valve”, has three leaflets that control the flow of blood between the two chambers on the right side of the heart. When those leaflets do not close properly, blood can flow in the reverse direction – known as regurgitation – forcing the heart to work harder. When left untreated, TR can lead to conditions such as atrial fibrillation, heart failure, and ultimately, death. The condition is difficult to treat, however, and options for patients have historically been extremely limited. People with TR are typically older and suffer from multiple co-morbidities, making open-heart surgery a high-risk procedure.
The TriClip procedure repairs the tricuspid valve without the need for open-heart surgery. The device is delivered to the heart through the femoral vein in the leg and works by clipping together a portion of the leaflets of the tricuspid valve to reduce the backflow of blood. This approach allows the heart to pump blood more efficiently, relieving symptoms of TR and improving a person’s quality of life.
“Patients suffering from severe tricuspid regurgitation are extremely ill and have very few treatment options,” said Georg Nickenig, M.D., Ph.D., professor and chief, Department of Cardiology, University Hospital, Bonn, Germany, and lead investigator of the TRILUMINATE trial, which generated strong data that helped lead to the CE Mark of TriClip. “Abbott’s TriClip could profoundly impact how physicians treat these patients. The therapy is backed by data proving safety and performance, durability, and improved patient quality of life.”
The CE Mark for TriClip follows positive six-month data from Abbott’s pivotal TRILUMINATE study examining edge-to-edge repair technique using TriClip, which was published in The Lancet in November 2019. The study demonstrated that TriClip reduced severity of TR and was associated with strong improvement in functional capacity and in quality of life at six months.
TriClip builds upon the proven success of Abbott’s MitraClip device, which treats people with leaky mitral valves, or mitral regurgitation (MR). TriClip leverages the same clip-based technology as MitraClip but has a differentiated delivery system designed specifically for delivery to the tricuspid valve. A new, steerable guiding catheter system adapts to the right side of the heart, where the tricuspid valve resides, enabling the physician to effectively grasp and clip the leaflets of the tricuspid valve. Additionally, the TriClip device is available in two different sizes (NT and XT) to accommodate different patient anatomies.
Read more